share_log

领航医药生物科技(00399.HK)获周耀庭场外增持5,000万股普通股股份,价值约1,050万港元

Pilot Pharmaceutical Biotechnology (00399.HK) received an additional 50 million shares of common stock worth approximately HK$10.5 million from Chow Yiu Ting

Futu News ·  Jan 9 17:04

On January 9, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on January 9, Chow Yiu-ting increased her OTC holdings at an average price of HK$0.21 per share on January 8$INNOVATIVE PHAR (00399.HK)$50 million common shares worth approximately HK$10.5 million. After the increase in holdings, Chow Yiu-ting's latest shareholding was 429 million shares, and the good position ratio increased from 22.70% to 25.69%.

HKEXAutoNews_IS20240108E00493.png

What is disclosure of interests?

As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. The directors and top executives of a listed company must disclose their interest in shares and debentures of the listed company and the company linked to the listed company.

Why is disclosure of interests important?

Disclosure of interests allows investors to identify (1) persons who control or are capable of controlling interest in shares of listed companies, and (2) persons who may benefit from transactions involving linked entities of listed companies.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment